Science

Merck Scraps COVID-19 Vaccine After Disappointing Immunization Results

MISSED THEIR SHOT

The company will now focus on manufacturing drugs for treatment of the virus, The Wall Street Journal reported on Monday.

GettyImages-151212973_qw8xe7
Arne Dedert/AFP/Getty

Got a tip? Send it to The Daily Beast here.